Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial-Reference-Cited by-同舟云学术

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial

Published:2019-01-31 Issue:7 Volume:114 Page:1071-1079
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Allegretti Jessica R.,Kassam Zain,Carrellas Madeline,Mullish Benjamin H.,Marchesi Julian R.,Pechlivanis Alexandros,Smith Mark,Gerardin Ylaine,Timberlake Sonia,Pratt Daniel S.,Korzenik Joshua R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. Update on inflammatory bowel disease in patients with primary sclerosing cholangitis;Tsaitas;World J Hepatol,2014

2. Primary sclerosing cholangitis;Lazaridis;N Engl J Med,2016

3. The IBD and PSC phenotypes of PSC-IBD;Ricciuto;Curr Gastroenterol Rep,2018

4. Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression;Sinakos;Hepatology,2010

5. Primary sclerosing cholangitis and the microbiota: Current knowledge and perspectives on etiopathogenesis and emerging therapies;Tabibian;Scand J Gastroenterol,2014

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polysaccharide-mediated modulation of gut microbiota in the treatment of liver diseases: Promising approach with significant challenges;International Journal of Biological Macromolecules;2024-09

2. Fecal microbiota transplantation: A potential novel treatment strategy for extensively drug-resistant tuberculosis;Medical Hypotheses;2024-08

3. Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers;Nutrients;2024-07-22

4. The gut microbiota-bile acid axis in cholestatic liver disease;Molecular Medicine;2024-07-19

5. Letter: Microbial manipulation for primary sclerosing cholangitis‐associated inflammatory bowel disease—hope on the horizon;Alimentary Pharmacology & Therapeutics;2024-07-16